Abstract
Chronic venous diseases afflict many people all over the world. Telangiectasias and reticular veins are considered as early manifestations of chronic venous disease. In this chapter, different causes and early manifestations of chronic venous diseases are discussed.
Similar content being viewed by others
References
Alder G, Lees T (2015) Foam sclerotherapy. Phlebology 30(2 Suppl):18–23
Alegre-Sanchez A, Jiménez-Gómez N, Moreno-Arrones ÓM, Fonda-Pascual P, Pérez-GarcÃa B, Jaén-Olasolo P, Boixeda P (2018) Treatment of flat and elevated pigmented disorders with a 755-nm alexandrite picosecond laser: clinical and histological evaluation. Lasers Med Sci 33(8):1827–1831
Anwar MA, Georgiadis KA, Shalhoub J, Lim CS, Gohel MS, Davies AH (2012) A review of familial, genetic, and congenital aspects of primary varicose vein disease. Circ Cardiovasc Genet 5(4):460–466
Barron GS, Jacob SE, Kirsner RS (2007) Dermatologic complications of chronic venous disease: medical management and beyond. Ann Vasc Surg 21(5):652–662
Bergan JJ, Weiss RA, Goldman MP (2000) Extensive tissue necrosis following high-concentration sclerotherapy for varicose veins. Dermatol Surg 26(6):535–541
Bergan JJ, Schmid-Schönbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B (2006) Chronic venous disease. N Engl J Med 355(5):488–498
Bergan JJ, Pascarella L, Schmid-Schönbein GW (2008) Pathogenesis of primary chronic venous disease: insights from animal models of venous hypertension. J Vasc Surg Venous Lymphat Disord 47(1):183–192
Bihari I, Magyar E (2001) Reasons for ulceration after injection treatment of telangiectasia. Dermatol Surg 27(2):133–136
Birgitte Maessen-Visch M, Koedam M, Hamulyak K, Neumann HA (1999) Atrophie blanche. Int J Dermatol 38:161
Brown K, Moore CJ (2010) Update on the treatment of saphenous reflux: laser, RFA or foam? Perspect Vasc Surg Endovasc Ther 21(4):226–231
Bryant Lyde C (2001) Atrophie blanche: a review from the perspective of a 31 patient cohort. Dermatol Ther 14(2):111
Caggiati A (2016) Ultrasonography of skin changes in legs with chronic venous disease. Eur J Vasc Endovasc Surg 52(4):534–542
Caggiati A, Rosi C, Franceschini M, Innocenzi D (2008) The nature of skin pigmentations in chronic venous insufficiency: a preliminary report. Eur J Vasc Endovasc Surg 35(1):111–118
Caggiati A, Rosi C, Casini A, Cirenza M, Petrozza V, Acconcia MC, Zamboni P (2010) Skin iron deposition characterises lipodermatosclerosis and leg ulcer. Eur J Vasc Endovasc Surg 40(6):777–782
Cavezzi A, Parsi K (2012) Complications of foam sclerotherapy. Phlebology 27(Suppl 1):46–51
Choonhakarn C, Chaowattanapanit S (2012) Lipodermatosclerosis: improvement noted with hydroxychloroquine and pentoxifylline. J Am Acad Dermatol 66(6):1013–1014
Choonhakarn C, Chaowattanapanit S, Julanon N (2016) Lipodermatosclerosis: a clinicopathologic correlation. Int J Dermatol 55(3):303–308
Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A (2006) Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs–UIP consensus document. Part I. Basic principles. Eur J Vasc Endovasc Surg 31(1):83–92
Davis LT, Duffy DM (1990) Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: a retrospective analysis. J Dermatol Surg Oncol 16(4):327–330
Dissemond J, Knab J, Lehnen M, Franckson T, Goos M (2004) Successful treatment of stasis dermatitis with topical tacrolimus. VASA 33(4):260–262
Duffy DM (2010) Sclerosants: a comparative review. Dermatol Surg 36(Suppl 2):1010–1025
Duffy DM (2012) Cosmetic applications of sclerotherapy. G Ital Dermatol Venereol 147(1):45–63
Eberhardt RT, Raffetto JD (2014) Chronic venous insufficiency. Circulation 130(4):333–346
Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW, American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification (2004) Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 40(6):1248–1252
Falanga V, Kuskal J, Franks JJ (1991) Fibrin and fibrinogen-related antigens in patients with lipodermatosclerosis and venous ulceration. Arch Dermatol 127(1):75–78
Friedmann DP, Liolios AM, Goldman MP (2014) An update on the treatment of lower extremity veins. Curr Derm Rep 3:113–121
Friedmann DP, Liolios AM, Wu DC, Goldman MP, Eimpunth S (2015) A randomized, double-blind, placebo-controlled study of the effect of a high-potency topical corticosteroid after sclerotherapy for reticular and telangiectatic veins of the lower extremities. Dermatol Surg 41(10):1158–1163
Georgiev M (1990) Postsclerotherapy hyperpigmentations: a one-year follow-up. J Dermatol Surg Oncol 16(7):608–610
Gniadecka M, Karlsmark T, Bertran A (1998) Removal of dermal edema with class I and II compression stockings in patients with lipodermatosclerosis. J Am Acad Dermatol 39(6):966–970
Goldman MP, Kaplan RP, Duffy DM (1987) Postsclerotherapy hyperpigmentation: a histologic evaluation. J Dermatol Surg Oncol 13(5):547–550
Goldman MP, Weiss RA, Bergan JJ (1994) Diagnosis and treatment of varicose veins: a review. J Am Acad Dermatol 31(3 Pt 1):393–413
Goldman MP, Sadick NS, Weiss RA (1995) Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment. Dermatol Surg 21(1):19–29
Guex JJ (2009) Complications and side-effects of foam sclerotherapy. Phlebology 24(6):270–274
Guex J, Schliephake DE, Otto J, Mako S, Allaert FA (2010) The French polidocanol study on long-term side effects: a survey covering 3,357 patient years. Dermatol Surg 36(Suppl 2):993–1003
Hafner C, Wimmershoff M, Landthaler M, Vogt T (2005) Lipodermatosclerosis: successful treatment with danazol. Acta Derm Venereol 85(4):365–366
Henriquez-Santana A, Fernandez-Guarino M, González de Olano D, Gonzalez-Cervera J, Huertas-Barbudo B, Aldanondo I (2008) Urticaria induced by Etoxisclerol (polidocanol). J Eur Acad Dermatol Venereol 22(1):261–262
Herouy Y, Mellios P, Bandemir E, Dichmann S, Nockowski P, Schöpf E, Norgauer J (2001) Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression. J Dermatol Sci 25(3):198–205
Huang TM, Lee JY (2009) Lipodermatosclerosis: a clinicopathologic study of 17 cases and differential diagnosis from erythema nodosum. J Cutan Pathol 36(4):453–460
Jeong KH, Shin MK, Kim NI (2011) Refractory lipodermatosclerosis treated with intralesional platelet-rich plasma. J Am Acad Dermatol 65(5):e157–e158
Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C (2007) Systematic review of foam sclerotherapy for varicose veins. Br J Surg 94(8):925–936
Kalra M, Gloviczki P (2003) Surgical treatment of venous ulcers: role of subfascial endoscopic perforator vein ligation. Surg Clin North Am 83(3):671–705
Khilnani NM, Min RJ (2003) Duplex ultrasound for superficial venous insufficiency. Tech Vasc Interv Radiol 6(3):111–115
Krysa J, Jones GT, van Rij AM (2012) Evidence for a genetic role in varicose veins and chronic venous insufficiency. Phlebology 27(7):329–335
Labropoulos N, Delis K, Nicolaides AN, Leon M, Ramaswami G (1996) The role of the distribution and anatomic extent of reflux in the development of signs and symptoms in chronic venous insufficiency. J Vasc Surg 23(3):504–510
Labropoulos N, Kokkosis AA, Spentzouris G, Gasparis AP, Tassiopoulos AK (2010) The distribution and significance of varicosities in the saphenous trunks. J Vasc Surg 51(1):96–103
Lim CS, Davies AH (2009) Pathogenesis of primary varicose veins. Br J Surg 96(11):1231–1242
McVittie E, Halloway S (2015) Aetiology and management of atrophie blanche in chronic venous insufficiency. Br J Community Nurs 20(Suppl 12):S8–S13
Meissner MH (2012) What is the medical rationale for the treatment of varicose veins? Phlebology 27(Suppl 1):27–33
Meissner MH, Moneta G, Burnand K, Gloviczki P, Lohr JM, Lurie F, Mattos MA, McLafferty RB, Mozes G, Rutherford RB, Padberg F, Sumner DS (2007) The hemodynamics and diagnosis of venous disease. J Vasc Surg 46(Suppl S):4S–24S
Misciali C, Dika E, Baraldi C, Mirelli M, Stella A, Bertoncelli M, Patrizi A (2014) Vascular leg ulcers: histopathologic study of 293 patients. Am J Dermatopathol 36(12):977–983
Moore M, Mishra V, Friedmann DP, Goldman MP (2016) Minocycline-induced postsclerotherapy pigmentation successfully treated with a picosecond alexandrite laser. Dermatol Surg 42(1):133–134
Mutlak O, Aslam M, Standfield N (2018) The influence of exercise on ulcer healing in patients with chronic venous insufficiency. Int Angiol 37(2):160–168
Naoum JJ, Hunter GC (2007) Pathogenesis of varicose veins and implications for clinical management. Vascular 15(5):242–249
Naoum JJ, Hunter GC, Woodside KJ, Chen C (2007) Current advances in the pathogenesis of varicose veins. J Surg Res 141(2):311–316
Nesbitt C, Eifell RK, Coyne P, Badri H, Bhattacharya V, Stansby G (2011) Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery for great saphenous vein varices. Cochrane Database Syst Rev 10:CD005624
Nicolaides AN, Allegra C, Bergan J, Bradbury A, Cairols M, Carpentier P, Comerota A, Delis C, Eklof B, Fassiadis N, Georgiou N, Geroulakos G, Hoffmann U, Jantet G, Jawien A, Kakkos S, Kalodiki E, Labropoulos N, Neglen P, Pappas P, Partsch H, Perrin M, Rabe E, Ramelet AA, Vayssaira M, Ioannidou E, Taft A (2008) Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol 27(1):1–59
Oguzkurt L (2012) Ultrasonographic anatomy of the lower extremity superficial veins. Diagn Interv Radiol 18:423–430
Parsi K (2015) Interaction of detergent sclerosants with cell membranes. Phlebology 30(5):306–315
Parsi K, Hannaford P (2016) Intra-arterial injection of sclerosants: report of three cases treated with systemic steroids. Phlebology 31(4):241–250
Pimentel CL, Rodriguez-Salido MJ (2008) Pigmentation due to stasis dermatitis treated successfully with a noncoherent intense pulsed light source. Dermatol Surg 34(7):950–951
Raju S, Neglén P (2009) Clinical practice. Chronic venous insufficiency and varicose veins. N Engl J Med 360(22):2319–2327
Ramelet AA (1991) Müller phlebectomy. A new phlebectomy hook. J Dermatol Surg Oncol 17(10):814–816
Ramelet A (1997) Complications of ambulatory phlebectomy. Dermatol Surg 23(10):947–954
Sadick NS (1992) Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 18(10):883–886
Schuller-Petrović S, Pavlović MD, Schuller S, Schuller-Lukic B, Adamic M (2013) Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel. Phlebology 28(6):320–323
Scultetus AH, Villavicencio JL, Kao T, Gillespie DL, Ketron GD, Iafrati MD, Pikoulis E, Eifert S (2003) Microthrombectomy reduces postsclerotherapy pigmentation: multicenter randomized trial. J Vasc Surg 38(5):896–903
Segal S, Cooper J, Bolognia J (2000) Treatment of lipodermatosclerosis with oxandrolone in a patient with stanozolol-induced hepatoxicity. J Am Acad Dermatol 43(3):558–559
Smith SR, Goldman MP (1998) Tumescent anesthesia in ambulatory phlebectomy. Dermatol Surg 24(4):453–456
Sundaresan S, Migden MR, Silapunt S (2017) Stasis dermatitis: pathophysiology, evaluation, and management. Am J Clin Dermatol 18(3):383–390
Tafazzoli A, Rostan EF, Goldman MP (2000) Q-switched ruby laser treatment for postsclerotherapy hyperpigmentation. Dermatol Surg 26(7):653–656
Thomas P, Martin J, Braithwaite B (2016) Case report: inadvertent intra-arterial injection during sclerotherapy may not be the disaster you think. J Vasc Nurs 34(1):12–16
Uhl JF, Cornu-Thenard A, Satger B, Carpentier PH (2012) Clinical analysis of the corona phlebectatica. J Vasc Surg 55(1):150–153
Vesić S, Vuković J, Medenica LJ, Pavlović MD (2008) Acute lipodermatosclerosis: an open clinical trial of stanozolol in patients unable to sustain compression therapy. Dermatol Online J 14(2):1
Vivas A, Lev-Tov H, Kirsner RS (2016) Venous leg ulcers. Ann Intern Med 165(3):ITC17–ITC32
Weiss RA, Weiss MA (1990) Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol. J Dermatol Surg Oncol 16(9):800–804
Weiss RA, Weiss MA (1993) Doppler ultrasound findings in reticular veins of the thigh subdermic lateral venous system and implications for sclerotherapy. J Dermatol Surg Oncol 19(10):947–951
Weiss RA, Weiss MA (1995) Continuous wave venous Doppler examination for pretreatment diagnosis of varicose and telangiectatic veins. Dermatol Surg 21(1):58–62
Weiss MA, Hsu JT, Neuhaus I, Sadick NS, Duffy DM (2014) Consensus for sclerotherapy. Dermatol Surg 40(12):1309–1318
Yiannakopoulou E (2016) Safety concerns for sclerotherapy of telangiectases, reticular and varicose veins. Pharmacology 98:62–69
Zimmet SE (1993) The prevention of cutaneous necrosis following extravasation of hypertonic saline and sodium tetradecyl sulfate. J Dermatol Surg Oncol 19(7):641–646
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Friedmann, D.P., Safaian, C., Nichols, S.E., Alsaad, S.M.S. (2020). Venous Disease Management and Therapies. In: Smoller, B., Bagherani, N. (eds) Atlas of Dermatology, Dermatopathology and Venereology . Springer, Cham. https://doi.org/10.1007/978-3-319-45134-3_91-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-45134-3_91-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45134-3
Online ISBN: 978-3-319-45134-3
eBook Packages: Springer Reference MedicineReference Module Medicine